US Stock MarketDetailed Quotes

ZVRA Zevra Therapeutics

Watchlist
  • 9.585
  • +0.455+4.98%
Close Nov 22 16:00 ET
  • 9.640
  • +0.055+0.57%
Post 20:01 ET
511.61MMarket Cap-4500P/E (TTM)

Zevra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zevra Therapeutics Q3 2024 Earnings Date

Currency：USDNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
4.86M
3.70M
-1.17M
Miss Est.
+67.97%
+27.63%
-24.01%
EPS
-0.42
-0.69
-0.27
Miss Est.
-5.33%
-130.00%
-63.82%
Analyst Rating
Strong Buy

Nov 14, 2024

Zevra Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 31.058M--
--2024/Q4-- / 8.776M--
Nov 12, 20242024/Q33.695M / 4.863M--
Aug 13, 20242024/Q24.449M / 4.358M--
May 8, 20242024/Q13.425M / 3.759M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 31.058M--
--2024/Q4-- / 8.776M--
Nov 12, 20242024/Q33.695M / 4.863M--
Aug 13, 20242024/Q24.449M / 4.358M--
May 8, 20242024/Q13.425M / 3.759M--

Unlock Free Earnings Estimates

Zevra Therapeutics Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Nov 13 16:24 ET

  • 8-K: Zevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates

    Nov 12 16:29 ET

  • 10-Q: Q2 2024 Earnings Report

    Aug 14 14:30 ET

  • 8-K: Zevra Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights

    Aug 13 16:24 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 14, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data